The utility of measuring anti-Müllerian hormone in predicting menopause

References

• Nikolaou D, Templeton A. Early ovarian ageing: a hypothesis. Detection and clinical relevance. Hum Reprod 2003;18:1137–9
   PubMed Web of Science ®Google Scholar
• Te Velde ER, Pearson PL.The variability of female reproductive ageing. Hum Reprod Update 2002;8:141–54
   PubMed Web of Science ®Google Scholar
• Gold EB, Crawford SL, Avis NE, et al. Factors related to age at natural menopause: longitudinal analyses from SWAN. Am J Epidemiol 2013;178:70–83
   PubMed Web of Science ®Google Scholar
• Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One 2010;27;5(1)
   Google Scholar
• Cate RL, Mattaliano RJ, Hession C, et al. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 1986;45:685–98
   PubMed Web of Science ®Google Scholar
• Jost A. The age factor in the castration of male rabbit fetuses. Proc Soc Exp Biol Med 1947;66:302
   PubMed Web of Science ®Google Scholar
• Hutson J, Ikawa H, Donahoe PK. The ontogeny of Mullerian inhibiting substance in the gonads of the chicken. J Pediatr Surg 1981;16:822–7
   PubMed Web of Science ®Google Scholar
• Rajpert-De Meyts E, Jørgensen N, Graem N, Muller J, Cate RL, Skakkebaek NE. Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999;84:3836–44
   PubMed Web of Science ®Google Scholar
• Visser JA, Themmen AP. Anti-Mullerian hormone and folliculogenesis. Mol Cell Endocrinol 2005;234:81–6
   PubMed Web of Science ®Google Scholar
• Weenen C, Laven JSE, Von Bergh ARM, et al.Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77–83
   PubMed Web of Science ®Google Scholar
• Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction 2002;124:601–9
   PubMed Web of Science ®Google Scholar
• Kevenaar ME, Meerasahib MF, Kramer P, et al. Serum anti- mullerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 2006;147:3228–34
   PubMed Web of Science ®Google Scholar
• Cohen-Haguenauer O, Picard JY, Mattéi MG, et al. Mapping of the gene for anti-Mullerian hormone to the short arm of human chromosome 19. Cytogenet Cell Genet 1987;44:2–6
   PubMedGoogle Scholar
• Imbeaud S, Faure E, Lamarre I, et al. Insensitivity to anti-Mullerian hormone due to a mutation in the human anti-Mullerian hormone receptor. Nat Genet 1995;11:382–8
   PubMed Web of Science ®Google Scholar
• Lee MM, Donahoe PK, Hasegawa T, et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571–6
   PubMed Web of Science ®Google Scholar
• Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WH. A validated model of serum anti-müllerian hormone from conception to menopause. PLoS One 2011;6(7):e22024
   PubMed Web of Science ®Google Scholar
• Hadlow N, Longhurst K, McClements A, Natalwala J, Brown SJ, Matson PL. Variation in antimüllerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response. Fertil Steril 2013;99:1791–7
   PubMed Web of Science ®Google Scholar
• Kissell KA, Danaher MR, Schisterman EF, et al. Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women. Hum Reprod 2014;29:1764–72
   PubMed Web of Science ®Google Scholar
• Steiner AZ, Stanczyk FZ, Patel S, Edelman A. Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception 2010;81:245–8
   PubMed Web of Science ®Google Scholar
• Bleil ME, Gregorich SE, Adler NE, Sternfeld B, Rosen MP, Cedars MI. Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women. Fertil Steril 2014; 101:199–207
   PubMed Web of Science ®Google Scholar
• Plante B, Cooper G, Baird D, Steiner A. The impact of smoking on antimullerian hormone levels in women aged 38 to 50 years. Menopause 2010;17:571–6
   PubMed Web of Science ®Google Scholar
• Seifer DB, Golub ET, Lambert-Messerlian G, et al. Variations in serum mullerian inhibiting substance between white, black, and Hispanic women. Fertil Steril 2009;92:1674–8
   PubMed Web of Science ®Google Scholar
• La Marca A, Spada E, Sighinolfi G, et al. Age-specific nomogram for the decline in antral follicle count throughout the reproductive period. Fertil Steril 2011;95:684–8
   PubMed Web of Science ®Google Scholar
• Skalba P, Cygal A, Madej P, et al. Is the plasma anti-Mullerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol 2011;158:254–9
   PubMed Web of Science ®Google Scholar
• Freour T, Masson D, Mirallie S, et al. Active smoking compromises IVF outcome and affects ovarian reserve. Reprod Biomed Online 2008;16:96–102
   PubMed Web of Science ®Google Scholar
• Fuentes A, Munoz A, Pommer R, et al. Decreased anti-mullerian hormone concentration in follicular fluid of female smokers undergoing artificial reproductive techniques. Chemosphere 2012;88:403–6
   PubMed Web of Science ®Google Scholar
• Dafopoulos A, Dafopoulos K, Georgoulias P, et al. Smoking and AMH levels in women with normal reproductive history. Arch Gynecol Obstet 2010;282:215–19
   PubMed Web of Science ®Google Scholar
• Gleicher N, Kim A, Weghofer A, Barad DH. Differences in ovarian aging patterns between races are associated with ovarian genotpes and sub-genotypes of the FMR1 gene. Reprod Biol Endocrinol 2012;10:77
   PubMed Web of Science ®Google Scholar
• Li HW, Wong CY, Yeung WS, Ho PC, Ng EH. Serum anti-müllerian hormone level is not altered in women using hormonal contraceptives. Contraception 2011;83:582–5
   PubMed Web of Science ®Google Scholar
• Bentzen JG, Forman JL, Pinborg A, et al. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Reprod Biomed Online 2012;25:612–19
   PubMed Web of Science ®Google Scholar
• Kallio S, Puurunen J, Ruokonen A, Vaskivuo T, Piltonen T, Tapanainen JS. Antimüllerian hormone levels decrease in women using combined contraception independently of administration route. Fertil Steril 2013;99:1305–10
   PubMed Web of Science ®Google Scholar
• Malloy PJ, Peng L, Wang J, Feldman D. Interaction of the vitamin D receptor with a vitamin D response element in the mullerian-inhibiting substance (MIS) promoter: Regulation of MIS expression by calcitriol in prostate cancer cells. Endocrinology 2009; 150:1580–7
   PubMed Web of Science ®Google Scholar
• Merhi ZO, Seifer DB, Weedon J, et al. Circulating vitamin D correlates with serum antimullerian hormone levels in late reproductive-aged women: Women's Interagency HIV Study. Fertil Steril 2012;98:228–34
   PubMed Web of Science ®Google Scholar
• Dennis NA, Houghton LA, Jones GT, van Rij AM, Morgan K, McLennan IS. The level of serum anti-Müllerian hormone correlates with vitamin D status in men and women but not in boys. J Clin Endocrinol Metab 2012;97:2450–5
   PubMed Web of Science ®Google Scholar
• Casadei L, Madrigale A, Puca F, et al. The role of serum anti-mullerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome. Gynecol Endocrinol 2013;29:545–50
   PubMed Web of Science ®Google Scholar
• Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM. Can anti-mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab 2013;98:3332–40
   PubMed Web of Science ®Google Scholar
• Sahmay S, AydinY, Atakul N, Aydogan B, Kaleli S. Relation of antimullerian hormone with the clinical signs of hyperandrogenism and polycystic ovary morphology. Gynecol Endocrinol 2014;30:130–4
   PubMed Web of Science ®Google Scholar
• Hudson PL, Dougas I, Donahoe PK, et al. An immunoassay to detect human mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 1990;70: 16–22
   PubMed Web of Science ®Google Scholar
• Freour T, Mirallie S, Bach-Ngohou K, Denis M, Barriere P, Masson D. Measurement of serum anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). Clin Chim Acta 2007;375:162–4
   PubMed Web of Science ®Google Scholar
• Nelson SM, La Marca A. The journey from the old to the new AMH assay: how to avoid getting lost in the values. Reprod Biomed Online 2011;23:411–20
   PubMed Web of Science ®Google Scholar
• Kumar A, Kalra B, Patel A, McDavid L, Roudebush WE. Development of a second generation anti-Mullerian hormone (AMH) ELISA. J Immunol Methods 2010;362:51–9
   PubMed Web of Science ®Google Scholar
• Wallace AM, Faye SA, Fleming R, Nelson SM. A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II). Ann Clin Biochem 2011;48: 370–3
   PubMed Web of Science ®Google Scholar
• Li HW, Ng EH, Wong BP, Anderson RA, Ho PC, Yeung WS. Correlation between three assay systems for anti-Müllerian hormone (AMH) determination. J Assist Reprod Genet 2012;29: 1443–6
   PubMed Web of Science ®Google Scholar
• Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update 2014;20:370–85
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Solaymani-Dodaran M, Tohidi M, Gohari MR, Azizi F. Modeling age at menopause using serum concentration of anti-mullerian hormone. J Clin Endocrinol Metab 2013;98: 729–35
   PubMed Web of Science ®Google Scholar
• Iino K, Tarakida A, Abe K, et al. Role of antimüllerian hormone as a biomarker of the menopausal transition. Menopause 2013;20:218–22
   PubMed Web of Science ®Google Scholar
• Rustamov O, Smith A, Roberts SA, et al. The measurement of anti-Müllerian hormone: a critical appraisal. J Clin Endocrinol Metab 2014;99:723–32
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev 2009;30:465–93
   PubMed Web of Science ®Google Scholar
• Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010;65:161–6
   PubMed Web of Science ®Google Scholar
• Dossus L, Allen N, Kaaks R, et al. Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2010;127:442–51
   PubMed Web of Science ®Google Scholar
• Parsa P, Parsa B. Effects of reproductive factors on risk of breast cancer: a literature review. Asian Pac J Cancer Prev 2009;10: 545–50
   PubMed Web of Science ®Google Scholar
• Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res 2011;1379:188–98
   PubMed Web of Science ®Google Scholar
• Francucci CM, Ceccoli L, Caudarella R, Rilli S, Boscaro M. Skeletal effect of natural early menopause. J Endocrinol Invest 2010;33:39–44
   PubMedGoogle Scholar
• Bleil ME, Gregorich SE, McConnell D, Rosen MP, Cedars MI. Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease? Menopause 2013;20:1139–46
   PubMed Web of Science ®Google Scholar
• Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update 2007;13:559–65
   PubMed Web of Science ®Google Scholar
• Sowers MR, Eyvazzadeh AD, McConnell D, et al. Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008;93: 3478–83
   PubMed Web of Science ®Google Scholar
• Van Rooij IA, Tonkelaar I, Broekmans FJ, et al. Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004;11:601–6
   PubMedGoogle Scholar
• Van Rooij IA, Broekmans FJ, Scheffer GJ, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005;83:979–87
   PubMed Web of Science ®Google Scholar
• Shin SY, Lee JR, Noh GW, et al. Analysis of serum levels of antimullerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein-3, and follicle-stimulating hormone with respect to age and menopausal status. J Korean Med Sci 2008;23:104–10
   PubMed Web of Science ®Google Scholar
• Nelson SM, Messow MC, McConnachie A, et al. External validation of nomogram for the decline in serum anti-Mullerian hormone in women: a population study of 15,834 infertility patients. Reprod Biomed Online 2011;23:204–6
   PubMed Web of Science ®Google Scholar
• Van Disseldorp J, Faddy MJ, Themmen AP, et al. Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab 2008;93:2129–34
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Shakeri N, Solaymani-Dodaran M, Azizi F. Predicting age at menopause from serum antimullerian hormone concentration. Menopause 2011;18:766–70
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Mansournia MA, Solaymani-Dodaran M, Azizi F. Age-specific serum anti-Müllerian hormone levels: estimates from a large population-based sample. Climacteric 2014; 17:591–7
   PubMed Web of Science ®Google Scholar
• Broer SL, Eijkemans MJ, Scheffer GJ, et al. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab 2011;96: 2532–9
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Lin H, Gracia CR. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab 2012;97:1673–80
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Lin H, Boorman DW, Gracia CR. Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women. Fertil Steril 2012;98:1254–9
   PubMed Web of Science ®Google Scholar
• La Marca A, Sighinolfi G, Papaleo E, Cagnacci A, Volpe A, Faddy MJ. Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. PLoS One 2013;8(3):e57005
   PubMed Web of Science ®Google Scholar
• Dólleman M, Faddy MJ, van Disseldorp J, et al. The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies. J Clin Endocrinol Metab 2013; 98:1946–53
   PubMed Web of Science ®Google Scholar
• Bentzen JG, Forman JL, Larsen EC, et al. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age. Hum Reprod 2013;28:247–55
   PubMed Web of Science ®Google Scholar
• Dólleman M, Depmann M, Eijkemans MJ, et al. Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother’s age at menopause. Hum Reprod 2014;29:584–91
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Solaymani-Dodaran M, Azizi F. A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause 2009;16:797–802
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Solaymani-Dodaran M, Hedayati M, Azizi F. Is polycystic ovary syndrome an exception for reproductive aging? Hum Reprod 2010;25:1775–81
   PubMed Web of Science ®Google Scholar